首页 > 市场调查报告书 > 製药

动物用医药

市场调查报告书

商品编码

1741320

施马伦贝格病毒治疗市场：按治疗类型、动物类型、按最终用户、按地区

Schmallenberg Virus Treatment Market, By Treatment Type, By Animal Type, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

施马伦贝格病毒治疗市场规模预计在 2025 年为 1.292 亿美元，预计到 2032 年将达到 2.272 亿美元，2025 年至 2032 年的复合年增长率为 8.4%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	1.292亿美元
效能数据	2020-2024	预测期	2025-2032
预测期间：2025年至2032年的复合年增长率	8.40%	2032年价值预测	2.272亿美元

施马伦贝格病毒是一种主要感染欧洲反刍动物的病原体，以其2011年在德国首次发现的小镇命名。此病毒主要透过媒介三带喙库蚊传播。受感染的牛、羊、山羊等牲畜常出现轻度至中度症状，如发烧、产乳量减少、生育能力下降等。在怀孕的牲畜中，尤其是牛和母羊，该病毒可导致后代先天畸形和死产，对畜牧生产构成重大威胁。施马伦贝格病毒已蔓延至欧洲各国，受感染的农场因生产力下降和繁殖问题而遭受经济损失。目前尚无针对该动物传播病毒的特效治疗方法，但预防和控制策略包括在可能的情况下控制媒介，并在一些地区实施疫苗接种计画。值得注意的是，该病毒主要感染动物，不认为对人类健康造成重大风险。正在进行的研究和开发重点是了解病毒、阐明其传播动态、开发更有效的疫苗和控制措施，以保护牲畜和农业免受其影响。

预防和控制施马伦贝格病毒需要采取一系列措施，包括控制媒介以减少耳螨暴露、进行疫苗接种计划（在可能的情况下）以及密切监测牲畜的感染征兆。需要强调的是，该病毒主要感染牲畜，不会对人类健康造成重大风险。正在进行的研究和开发旨在更好地了解该病毒及其传播动态，并开发更有效的疫苗和控制策略，从而减少其对牲畜和欧洲农业部门的影响。

市场动态

预计在预测期内，相关发展、认知度的提升以及研发工作将推动全球施马伦贝格病毒治疗市场的成长。此外，支持性措施也预计将在预测期内促进全球施马伦贝格病毒治疗市场的成长。疫苗研发、抗病毒药物、支持性护理解决方案以及诊断工具预计将在预测期内为全球施马伦贝格病毒治疗市场带来成长机会。

然而，有限的治疗选择、疫苗开发的复杂性以及较低的经济奖励预计将在预测期内阻碍施马伦贝格病毒治疗市场的成长。

研究的主要特点

本报告对施马伦贝格病毒治疗市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025-2032 的市场规模和復合年增长率。
它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
施马伦贝格病毒治疗市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
施马伦贝格病毒治疗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过施马伦贝格病毒治疗市场分析中使用的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 129.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.40%	2032 Value Projection:	USD 227.2 Mn

Schmallenberg virus is a pathogen that primarily affects ruminant livestock in Europe, with its name derived from the German town where it was first identified in 2011. This virus is mainly transmitted by Culicoides midges, which serve as vectors for its spread. When livestock, such as cattle, sheep, and goats, are infected, they often display mild to moderate symptoms, including fever, reduced milk production, and decreased fertility. In pregnant animals, particularly cows and ewes, the virus can lead to congenital malformations in the offspring and stillbirths, posing a significant threat to livestock production.The Schmallenberg virus has extended its reach to various European countries, causing economic losses for affected farms due to reduced productivity and reproductive issues. While there is no specific treatment for the virus in animals, prevention and control strategies involve vector control, when possible, as well as vaccination programs in some regions. Notably, the virus primarily affects animals and is not considered a substantial risk to human health. Ongoing research efforts continue to focus on understanding the virus, its transmission dynamics, and the development of more effective vaccines and control measures to safeguard livestock and the agricultural industry from its impact.

Preventing and controlling the Schmallenberg virus involves various measures, including vector control to limit midge exposure, vaccination programs where available, and vigilant monitoring for signs of infection in livestock. It's worth emphasizing that the virus primarily affects animals and does not pose a significant risk to human health. Ongoing research efforts are dedicated to better understanding the virus, its transmission dynamics, and the development of more effective vaccines and control strategies to mitigate its impact on livestock and the agricultural sector in Europe.

Market Dynamics:

Emerging outbreaks, growing awareness, and research and development are anticipated to drive growth of the global Schmallenberg virus treatment market over the forecast period. Moreover, supportive measures are also expected to boost the growth of the global Schmallenberg virus treatment market over the forecast period. Vaccine development, antiviral drugs, supportive care solutions and diagnostic tools are expected to create growth opportunities for the global Schmallenberg virus treatment market during the forecast period.

However, limited treatment options, the complexity of vaccine development, and low economic incentives are expected to hamper growth of the Schmallenberg virus treatment market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the Schmallenberg virus treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Schmallenberg virus treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, MSD Animal Health (Merck Animal Health), Elanco Animal Health, Ceva Sante Animale, Virbac, Bayer Animal Health, Vetoquinol, Huvepharma, IDT Biologika, Heska Corporation, Dechra Pharmaceuticals, Phibro Animal Health, Neogen Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Schmallenberg virus treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Schmallenberg virus treatment market

Schmallenberg Virus Treatment Market Detailed Segmentation:

By Treatment Type:
- Antiviral Drugs
- Anti-inflammatory Drugs
- Analgesics
- Vaccines
- Others
By Animal Type:
- Cattle
- Sheep
- Goats
- Others
By End User:
- Veterinary Hospitals and Clinics
- Research Institutions
- Veterinary Pharmacies and Drug Store
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profile:
- Boehringer Ingelheim
- Zoetis
- MSD Animal Health (Merck Animal Health)
- Elanco Animal Health
- Ceva Sante Animale
- Virbac
- Bayer Animal Health
- Vetoquinol
- Huvepharma
- IDT Biologika
- Heska Corporation
- Dechra Pharmaceuticals
- Phibro Animal Health
- Neogen Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Schmallenberg Virus Treatment, By Treatment Type
- Market Schmallenberg Virus Treatment, By Animal Type
- Market Schmallenberg Virus Treatment, By End User
- Market Schmallenberg Virus Treatment, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Emerging Outbreaks
Growing Awareness
Research and Development
Supportive Measures
- Restraints
Limited Treatment Options
Complexity of Vaccine Development
- Opportunities
Vaccine development
Antiviral Drugs
Supportive Care Solutions
Diagnostic Tools
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Schmallenberg Virus Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Schmallenberg Virus Treatment Market, By Treatment Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Antiviral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Schmallenberg Virus Treatment Market, By Animal Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Goats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Schmallenberg Virus Treatment Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Veterinary Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Veterinary Pharmacies and Drug Store
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Schmallenberg Virus Treatment Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - North Africa
  - Central Africa
  - Rest of Middle East & Africa

9. Competitive Landscape

Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zoetis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MSD Animal Health (Merck Animal Health)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ceva Sante Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vetoquinol
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Huvepharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IDT Biologika
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Heska Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Phibro Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nogen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

施马伦贝格病毒治疗市场：按治疗类型、动物类型、按最终用户、按地区